DSM-Firmenich revenue and financials

DSFIR · Euronext Amsterdam · EUR

Compare DSM-Firmenich
€103.60Change from previous close: −0.53%Absolute change: −€0.55

Close · November 17, 2026

In the fiscal year ended December 2025, DSM-Firmenich reported revenue of €9.03B (−0.22% year over year). The net loss was €1.08B.

Annual revenue · 2025: €9.03B
  1. €7.92B2016
  2. €8.63B2017
  3. €9.27B2018
  4. €8B2019
  5. €8.11B2020
  6. €7.27B2021
  7. €8.39B2022
  8. €10.63B2023
  9. €9.05B2024
  10. €9.03B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
−0.22%
2025 vs 2024
Net margin
-12.0%
2024: 2.8%

How DSM-Firmenich is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue9,0349,05410,6278,3907,2698,1067,9989,2678,6327,920
Cost of revenue5,5045,5018,0165,7004,6575,3305,2345,8625,6995,262
Gross profit3,5303,5532,6112,6902,6122,7762,7643,4052,9332,658
Selling, general and administrative2,2092,2072,5351,7721,6491,6221,6391,8391,7531,694
Research and development713814652295274398295348334309
Operating income629527-5606527106728071,209797625
EBIT629527-5606527106728071,209797625
EBITDA1,4381,3763451,2341,3051,2091,2851,6671,2541,080
Interest expense15415713810492.090.096.097.0122118
Pre-tax income460423-6545999535638341,2731,896746
Income tax11864.0-18.012412310614519411589.0
Net income-1,0812502,1371,7001,6765067581,0771,769621
Net income to common shareholders274301-6584548204486751,0691,761645
Basic EPS1.061.14-2.822.634.752.613.846.1010.073.68
Diluted EPS1.051.14-2.822.614.732.593.826.0610.043.67
Average shares (basic)259265233173173172176175175175
Average shares (diluted)259265233173173172177176175176
Dividend per share2.502.502.502.532.502.402.402.301.851.75

Companies in the group: same industry, similar size